Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/28807
Full metadata record
DC FieldValueLanguage
dc.contributor.authorNg, Felix C-
dc.contributor.authorChurilov, Leonid-
dc.contributor.authorYassi, Nawaf-
dc.contributor.authorKleinig, Timothy J-
dc.contributor.authorThijs, Vincent N-
dc.contributor.authorWu, Teddy Y-
dc.contributor.authorShah, Darshan G-
dc.contributor.authorDewey, Helen M-
dc.contributor.authorSharma, Gagan-
dc.contributor.authorDesmond, Patricia M-
dc.contributor.authorYan, Bernard-
dc.contributor.authorParsons, Mark W-
dc.contributor.authorDonnan, Geoffrey A-
dc.contributor.authorDavis, Stephen M-
dc.contributor.authorMitchell, Peter J-
dc.contributor.authorLeigh, Richard-
dc.contributor.authorCampbell, Bruce C V-
dc.date2022-02-09-
dc.date.accessioned2022-02-22T04:28:57Z-
dc.date.available2022-02-22T04:28:57Z-
dc.date.issued2022-06-
dc.identifier.citationStroke 2022; 53(6): 1915-1923en
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/28807-
dc.description.abstractEmerging data suggest tissue within the infarct lesion is not homogenously damaged following ischemic stroke but has a gradient of injury. Using blood-brain-barrier (BBB) disruption as a marker of tissue injury, we tested whether therapeutic reperfusion improves clinical outcome by reducing the severity of tissue injury within the infarct in patients with ischemic stroke. In a pooled analysis of patients treated for anterior circulation large vessel occlusion in the EXTEND-IA TNK (Tenecteplase Versus Alteplase Before Endovascular Therapy for Ischemic Stroke) and EXTEND-IA part-2 (Determining the Optimal Dose of Tenecteplase Before Endovascular Therapy for Ischaemic Stroke) trials, post-treatment BBB permeability at 24 hours was calculated based on the extent of T1-brightening by extravascular gadolinium on T2* perfusion-weighted imaging and measured within the diffusion-weighted-imaging lesion. First, to determine the clinical significance of BBB disruption as a marker of severity of tissue injury, we examined the association between post-treatment BBB permeability and functional outcome. Second, we performed an exploratory (reperfusion, BBB permeability, functional outcome) mediation analysis to estimate the proportion of the reperfusion-outcome relationship that is mediated by change in BBB permeability. In the 238 patients analyzed, an increased BBB permeability measured within the infarct at 24 hours was associated with a reduced likelihood of favorable outcome (90-day modified Rankin Scale score of ≤2) after adjusting for age, baseline National Institutes of Health Stroke Scale, premorbid modified Rankin Scale, infarct topography, laterality, thrombolytic agent, sex, parenchymal hematoma, and follow-up infarct volume (adjusted odds ratio, 0.86 [95% CI, 0.75-0.98], P=0.023). Mediation analysis suggested reducing the severity of tissue injury (as estimated by BBB permeability) accounts for 18.2% of the association between reperfusion and favorable outcome, as indicated by a reduction in the regression coefficient of reperfusion after addition of BBB permeability as a covariate. In patients with ischemic stroke, reduced severity of tissue injury within the infarct, as determined by assessing the integrity of the BBB, is independently associated with improved functional outcome. In addition to reducing diffusion-weighted imaging-defined infarct volume, reperfusion may also improve clinical outcome by reducing tissue injury severity within the infarct.en
dc.language.isoeng-
dc.subjectblood-brain barrieren
dc.subjectinfarctionen
dc.subjectischemic strokeen
dc.subjectreperfusionen
dc.subjectthrombectomyen
dc.titleReduced Severity of Tissue Injury Within the Infarct May Partially Mediate the Benefit of Reperfusion in Ischemic Stroke.en
dc.typeJournal Articleen
dc.identifier.journaltitleStrokeen
dc.identifier.affiliationNeurology..en
dc.identifier.affiliationThe Florey Institute of Neuroscience and Mental Health..en
dc.identifier.affiliationMelbourne Medical School, The University of Melbourne, Heidelberg, Victoria, Australia..en
dc.identifier.affiliationDepartment of Medicine and Neurology, Melbourne Brain Centre at the Royal Melbourne Hospital, University of Melbourne, Parkville, Australia..en
dc.identifier.affiliationDepartment of Neurology, Princess Alexandra Hospital, Brisbane, Australia..en
dc.identifier.affiliationDepartment of Radiology, Royal Melbourne Hospital, University of Melbourne, Parkville, Australia..en
dc.identifier.affiliationDepartment of Neurology, Royal Adelaide Hospital, Australia..en
dc.identifier.affiliationEastern Health and Eastern Health Clinical School, Department of Neurosciences, Monash University, Clayton, Australia..en
dc.identifier.affiliationDepartment of Neurology, Christchurch Hospital, New Zealand..en
dc.identifier.affiliationDepartment of Neurology, John Hopkins University, Baltimore, MD..en
dc.identifier.affiliationPopulation Health and Immunity Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia..en
dc.identifier.pubmedurihttps://pubmed.ncbi.nlm.nih.gov/35135319/en
dc.identifier.doi10.1161/STROKEAHA.121.036670en
dc.type.contentTexten
dc.identifier.orcid0000-0001-6973-8677en
dc.identifier.orcid0000-0002-9807-6606en
dc.identifier.orcid0000-0002-0685-0060en
dc.identifier.orcid0000-0003-4430-3276en
dc.identifier.orcid0000-0002-6614-8417en
dc.identifier.orcid0000-0003-1845-1769en
dc.identifier.orcid0000-0002-5254-219Xen
dc.identifier.orcid0000-0001-9484-2070en
dc.identifier.orcid0000-0002-4803-6323en
dc.identifier.orcid0000-0001-8802-9606en
dc.identifier.orcid0000-0001-8874-2487en
dc.identifier.orcid0000-0001-6324-3403en
dc.identifier.orcid0000-0003-0962-2300en
dc.identifier.orcid0000-0002-8337-7529en
dc.identifier.orcid0000-0002-8285-1815en
dc.identifier.orcid0000-0003-3632-9433en
dc.identifier.pubmedid35135319-
local.name.researcherChurilov, Leonid
item.languageiso639-1en-
item.fulltextNo Fulltext-
item.grantfulltextnone-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
item.openairetypeJournal Article-
crisitem.author.deptNeurology-
crisitem.author.deptMedicine (University of Melbourne)-
crisitem.author.deptThe Florey Institute of Neuroscience and Mental Health-
crisitem.author.deptNeurology-
crisitem.author.deptThe Florey Institute of Neuroscience and Mental Health-
crisitem.author.deptThe Florey Institute of Neuroscience and Mental Health-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

90
checked on Dec 25, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.